The Middle East & Africa Drug Screening Market size has been calculated at USD 0.44 billion in 2023. It is expected to grow at a CAGR of 7.92% and be worth USD 0.64 billion by 2028.
The Increasing drug and alcohol consumption and Strict laws mandating drug and alcohol testing are majorly driving the Drug screening market in Middle East Africa. In addition, growing substance user treatment admission is raising the demand for drug screening devices. Since South Africa has the highest alcohol consumption rates in this region, according to African Medical Research Council, more than 11 percent of people will suffer from an addiction disorder.
The increasing usage of drugs among adults in emerging countries such as South Africa has impacted employment and disrupted the country's economic position, significantly influencing the market growth. In addition, the increase in the strict government rules and regulations for controlling the drug market, raising awareness regarding drug screening policy, and heavy consumption of alcohol with its consequences are projected to fuel the market growth.
On the other hand, regulatory approval and product launches, the increase in competition between players for developing new advanced products by acquiring various market strategies such as acquisitions and collaborations will increase the demand for drug screening products. Also, the key manufacturers in the market are engaged in developing innovative products, which are expected to accelerate the market growth.
Moreover, increasing initiatives and investment from government and non-government firms in research activity for developing advanced and efficient screening devices for improving the demand in the market is expected to accelerate the market growth. In addition, non-government organizations are investing in sponsoring screening products to enhance the advanced drug screening methods. Authorities in the region primarily focus on implementing comprehensive drug and alcohol testing to measure illegal drug consumption, which is expected to positively influence market growth.
However, the high costs of the drug screening equipment are the primary factor limiting the market growth. In addition, the strict government rules and regulations for alcohol and drug consumption as consumption of these substances are strictly prohibited in some regions and countries such as Saudi Arabia, UAE is affecting the growth of the drug screening market. The other factor that hinders the market growth is the issues related to the accuracy and efficiency of the screening device and the restriction pertaining to practicing drug tests at a low rate. Also, the presence of various substitutes in screening devices in the market is restraining the growth of the MEA drug screening market.
This research report on the Middle East and Africa Drug Screening Market has been segmented and sub-segmented into the following categories:
By Sample Type:
By End-user:
By Products and Services:
By Country:
The Middle East and Africa are anticipated to record a moderate share in the global drug screening market during the forecast period. The increasing drug and alcohol consumption in emerging countries such as Africa and Saudi Arabia contributes to the MEA regional market growth. In addition, improving healthcare sectors, the presence of key market players, and favorable reimbursement policies are expected to boost the market growth.
South Africa held the largest share of the growth in recent years due to the increase in alcohol consumers and illegal drug traffic. The increasing alcohol consumption has been coupled with impaired senses while driving, which needs to be tested and penalized. However, the illegal use of drugs in sports events also increases the demand for drug screening devices in the country.
Saudi Arabia and the UAE are also expected to grow due to increasing alcoholism and illegal drug abuse. Also, the increase in the growing awareness about drug and alcohol screening policies with the rise in disposable income is expected to fuel the market growth.
KEY MARKET PLAYERS:
Companies that dominate the MEA Drug Screening Market profiled in the report are Thermo Fisher Scientific Inc., Express Diagnostics Int’l Inc., Abbott Laboratories, Siemens AG, Alere Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Biorad Laboratories Inc., Shimadzu, and Omega Laboratories.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region